ResearcherColumbia University Irving Medical CenterActive in the last 2 years

Talita Ferreira Marques Aguiar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0202-6848; OpenAlex author ID A5003501488. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1501943 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Emmanuel Zorn · 1 shared paper, 2025 · strength 0.21
- Paper Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic du… DOI 10.3389/fimmu.2025.1501943 ↗
Jeanine M. Genkinger · 1 shared paper, 2025 · strength 0.21
- Paper Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic du… DOI 10.3389/fimmu.2025.1501943 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.